What is the recommended dosage of nitrofurantoin for uncomplicated urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Dosing for Uncomplicated UTIs

For uncomplicated urinary tract infections (UTIs) in women, the recommended dosage of nitrofurantoin is 100 mg twice daily for 5 days in the form of nitrofurantoin monohydrate/macrocrystals. 1

Recommended Dosing Regimens by Patient Population

Women with Uncomplicated UTIs

  • Nitrofurantoin monohydrate/macrocrystals: 100 mg twice daily for 5 days 2, 1
  • Alternative formulation: Nitrofurantoin macrocrystals 50-100 mg four times daily for 5 days 1

Men with UTIs

  • Nitrofurantoin 100 mg every 6 hours for 7-14 days (14 days recommended when prostatitis cannot be excluded) 3

Efficacy Data

  • Clinical cure rates with nitrofurantoin range from 88-93% for uncomplicated UTIs in women 1, 4
  • Bacterial cure rates range from 81-92% 1, 4
  • The 5-day regimen of nitrofurantoin monohydrate/macrocrystals (100 mg twice daily) has been shown to be equivalent to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) in clinical and microbiological cure rates 1
  • Early clinical cure rates are approximately 90% 2

Important Contraindications and Precautions

  • Contraindicated in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations 4, 3
  • Avoid in the last three months of pregnancy 5
  • Not recommended if early pyelonephritis is suspected 1, 3

Treatment Duration Considerations

  • While the Infectious Diseases Society of America (IDSA) and European Society for Microbiology and Infectious Diseases recommend 5-day regimens 2, 1, some UK guidelines suggest 3-day courses 6
  • However, there is limited direct evidence supporting 3-day courses of nitrofurantoin, and the 5-day regimen has more robust evidence 6

Alternative First-Line Options When Nitrofurantoin Cannot Be Used

  • Fosfomycin trometamol 3 g single dose (slightly lower efficacy than nitrofurantoin) 1, 7
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local resistance rates <20% or if the infecting strain is confirmed susceptible) 2, 1

Common Side Effects

  • Nausea and headache are most commonly reported 1
  • Adverse event rates range from 5.6-34% across studies 2, 1
  • Headache occurs in approximately 10.8% of patients 8

Clinical Pearls

  • Nitrofurantoin has maintained good activity against common uropathogens despite decades of use 5
  • It is considered a first-line agent due to minimal resistance and limited propensity for collateral damage 1, 4
  • For patients with persistent or recurrent symptoms, obtain urine culture with susceptibility testing 3
  • In randomized controlled trials, nitrofurantoin has shown significantly better efficacy than placebo in achieving both bacteriological cure and symptomatic relief 9

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrofurantoin Dosing for Male UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Clinical Efficacy and Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.